MPC vs SKYE · P/E 16, rev $138.86B vs $25.0M cap
Marathon Petroleum Corp (MPC) versus Skye Bioscience, Inc. Common Stock (SKYE) — a side-by-side from cached financials, not a winner call.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
Skye Bioscience, Inc. Common Stock (SKYE) is a biotechnology company listed on NASDAQ.
Latest reported MPC revenue for 2024-12-31 was $138.86B. Net income was $5.07B. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
SKYE does not have a complete income-statement cache yet.
MPC currently screens at market cap $71.41B and trailing P/E 16.1. SKYE currently screens at market cap $25.0M.
Not investment advice. Open the MPC and SKYE stock pages for the full models.
Not investment advice.